Product Information
VYVANSE 10 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.3509 per EA under NDC 59417010110. Its NADAC has been published 584 times since Apr 22, 2015.
The High Outlier badge above means this manufacturer's average price in the lisdexamfetamine dimesylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
59417010110
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA021977On Market Since
8/30/2014
Pharmacological Classes
Price Statistics
The NADAC for VYVANSE 10 MG CAPSULE has been published 584 times since Apr 22, 2015, and over the history we have for it it has risen 77.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3509 per EA |
|---|---|
| All-time high | $12.3892 (Aug 14, 2024) |
| All-time low | $6.9495 (Apr 22, 2015) |
| 52-week high | $12.3716 |
| 52-week low | $12.3508 |
| Median price | $10.2177 |
| Average price | $10.3098 |
| Largest weekly change | +9.0% (Jan 11, 2017) |
| Weeks tracked | 584 |
| Tracking since | Apr 22, 2015 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 77% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VYVANSE 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VYVANSE 10 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $12.3509 per EA (NDC 59417010110), effective Jun 24, 2026.
How has the price of VYVANSE 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VYVANSE 10 MG CAPSULE has risen 77.7%. It has been tracked across 584 weekly CMS publications since Apr 22, 2015.
What are the highest and lowest recorded NADAC prices for VYVANSE 10 MG CAPSULE?
Since Apr 22, 2015, the NADAC for VYVANSE 10 MG CAPSULE has ranged from a low of $6.9495 (Apr 22, 2015) to a high of $12.3892 (Aug 14, 2024), with a median of $10.2177 per EA.
Are there cheaper alternatives to VYVANSE 10 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LISDEXAMFETAMINE 10 MG CAPSULE, is $2.8732 per EA — about 77% below VYVANSE 10 MG CAPSULE.
Who manufactures VYVANSE 10 MG CAPSULE?
VYVANSE 10 MG CAPSULE (NDC 59417010110) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification